Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction.
about
Diabetic ketoacidosis presenting with atypical hemolytic uremic syndrome associated with a variant of complement factor B in an adult: a case report.Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenzaHyperketonemia (acetoacetate) upregulates NADPH oxidase 4 and elevates oxidative stress, ICAM-1, and monocyte adhesivity in endothelial cells.Biomarkers and genetics of brain injury risk in diabetic ketoacidosis: A pilot studyEffects of Diabetic Ketoacidosis on Visual and Verbal Neurocognitive Function in Young Patients Presenting with New-Onset Type 1 Diabetes1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis).Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes.Circulating matrix metalloproteinases in children with diabetic ketoacidosis.Simulated diabetic ketoacidosis therapy in vitro elicits brain cell swelling via sodium-hydrogen exchange and anion transport.Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis.CXCL1/CXCL8 (GROα/IL-8) in human diabetic ketoacidosis plasma facilitates leukocyte recruitment to cerebrovascular endothelium in vitroSuccessful Treatment of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Status in an Infant with KCNJ11-Related Neonatal Diabetes Mellitus via Continuous Renal Replacement Therapy
P2860
Q33430267-E248280C-4705-40E5-BF15-505BBC218543Q33670505-3724E13A-1698-4C6E-A0D0-0BED17F7DDC9Q35022262-F5F14F3B-D1B4-4F6A-88DE-8673454D56ABQ35755981-16D6E7BC-DC7C-4C28-865C-B34F34090855Q36367781-B6152A62-235D-4ECD-A215-AC78CF06BC8FQ36781035-5202984B-68CB-4A75-84E1-A6185E4AD803Q36901925-0541871E-3F46-4F12-A5B8-BE7CB9BFBB48Q37153161-C7007CBB-D30F-46DC-AD0D-EFEA2B2CDE62Q40829692-37EA5D2F-9998-44A9-B28B-7D6E68C4BD4FQ52147673-A95E40A5-5126-4D8B-A170-7F2730779BFBQ57076408-7F503C88-E098-4AA8-A0F8-32BF86A037F9Q58791929-A8F2AC92-510A-402E-8576-C6B4EA8075FD
P2860
Diabetic ketoacidosis elicits systemic inflammation associated with cerebrovascular endothelial cell dysfunction.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@en
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@nl
type
label
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@en
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@nl
prefLabel
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@en
Diabetic ketoacidosis elicits ...... endothelial cell dysfunction.
@nl
P2093
P2860
P356
P1433
P1476
Diabetic ketoacidosis elicits ...... r endothelial cell dysfunction
@en
P2093
Douglas D Fraser
Keeley L Rose
Kelly Summers
Tatsushi Omatsu
Taylor E Close
P2860
P304
P356
10.1111/MICC.12053
P577
2013-08-01T00:00:00Z